Cargando…
The impact of liposomal linolenic acid on gastrointestinal microbiota in mice
BACKGROUND: The prevalence of Helicobacter pylori has long been a global health issue. Triple therapy, being the first-line treatment, has caused dysbiosis of the gastrointestinal tract that led to various complications. A novel nanomedicine – liposomal linolenic acid (LipoLLA) – has been proven to...
Autores principales: | Li, Xuan-xuan, Shi, Si, Rong, Lan, Feng, Mei-qing, Zhong, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849918/ https://www.ncbi.nlm.nih.gov/pubmed/29563795 http://dx.doi.org/10.2147/IJN.S151825 |
Ejemplares similares
-
Mechanism of Antibacterial Activity of Liposomal Linolenic Acid against Helicobacter pylori
por: Jung, Sung Woo, et al.
Publicado: (2015) -
The Activity of Liposomal Linolenic Acid Against Helicobacter pylori In Vitro and Its Impact on Human Fecal Bacteria
por: Wang, Ya, et al.
Publicado: (2022) -
Acetate-encapsulated Linolenic Acid Liposomes Reduce SARS-CoV-2 and RSV Infection
por: McGill, Andrew R., et al.
Publicado: (2023) -
Antitumor Activity of α-Linolenic Acid-Paclitaxel Conjugate Nanoparticles: In vitro and in vivo
por: Xu, Mei-Qi, et al.
Publicado: (2021) -
Influence of linolenic acid in the production of jasmonate
por: Leite, Vera, et al.
Publicado: (2014)